Project Grant RF1NS139975
Award Date
9/19/24
Completion Date
8/31/27
Dollars Obligated
$11M
Funding Federal Agency
National Institute on Aging
Awarding Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94158, USA
Similar Awards
This federal Project Grant award, valued at $2,288,327 and provided by the National Institute on Aging (NIA) under CFDA Program 93.866 - Aging Research, supports research to investigate early determinants of Alzheimer's disease (AD) using age-equivalent neurons derived from mild cognitive impairment (MCI) patient samples. The project aims to integrate polygenic risk scores for AD with multi-omic profiling of MCI patient-derived induced neurons (iNs) to better understand the early trajectory of...
This federal Project Grant award of $2,833,089 was provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) to the J. David Gladstone Institutes. The award will support research to investigate the roles of the TREM2 and TYROBP genes and their impact on network hyperexcitability, which may contribute to cognitive decline in Alzheimer's disease and related dementias. Key objectives include determining whether TYROBP hypofunction exacerbates network...
This $614,424 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to better understand the role of microglia, the brain's immune cells, in the progression of Alzheimer's disease (AD). The University of Washington is the prime awardee and will leverage novel explainable AI techniques and human-induced pluripotent stem cell (iPSC) models to uncover subtle microglial changes occurring early in AD. Specific objectives include using AI to identify...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $372,690 to The Regents of the University of California (UC Berkeley) to conduct research aimed at understanding the heterogeneous causal pathophysiology of Alzheimer's disease (AD). The project seeks to develop new statistical methods to uncover the complex relationships between amyloid-beta, tau accumulation, and cognition in different AD subpopulations. The goal is to identify optimal...
This federal Project Grant award of $791,086 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop computational models that can predict the presence of non-Alzheimer's disease neuropathological changes (non-ADNC), such as Lewy body disease, TDP-43 proteinopathy, and cerebral amyloid angiopathy, in individuals with Alzheimer's disease neuropathological changes. The 5-year project, awarded to the Northern California Institute for Research and Education (NCIRE),...
This Project Grant award from the National Institute on Aging's Aging Research federal grant program (CFDA 93.866) provides $871,419 to the University of Washington to conduct research on the role of microglia, the brain's immune cells, in the pathogenesis of Alzheimer's disease. The research aims to characterize molecular profiles and spatial organization of microglia across the adult age spectrum, both with and without Alzheimer's disease, through single-nucleus RNA sequencing of over 5,000...
This $5,949,022 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to identify novel therapeutic targets for vascular contributions to cognitive impairment and dementia (VCID). The primary awardee, The Jackson Laboratory, in collaboration with Emory University, Columbia University, and Rush University Medical Center, will...
The National Institute on Aging (NIA) awarded a $7,249,563 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the Regents of the University of California, San Francisco (UCSF). This 3-year award, starting on Aug 1, 2023, will support research to characterize the structural properties and variability of tau protein aggregation in different brain cell types and at different disease stages of Alzheimer's and related dementias (ADRD). The project aims to develop new...
This federal Project Grant award, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), will support research to quantitatively test and validate hypotheses regarding the selective vulnerability of certain brain regions, cell types, and neural networks in mouse models of tauopathy, which is a pathological hallmark of Alzheimer's disease. The $4,276,054 grant, awarded to the Regents of the University of California, San Francisco, will leverage the researchers' recently...
This $156,000 federal Project Grant award, issued by the National Institute on Aging (CFDA 93.866 - Aging Research), supports research by Thomas Jefferson University (Sidney Kimmel Medical College) to develop a novel therapeutic strategy for Alzheimer's disease (AD). The key objectives are to: 1) Generate intrabodies to neutralize the RNA:DNA hybrids associated with AD pathogenesis, and 2) Validate the efficacy of these intrabodies in suppressing the cGAS-STING pathway activation in cerebral...